Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
ST. PAUL, Minn., July 20, 2012 (GLOBE NEWSWIRE) -- MEDTOX Scientific, Inc. (Nasdaq:MTOX) today announced that counsel for MEDTOX and other named defendants have today entered into a memorandum of...
ST. PAUL, Minn., July 13, 2012 (GLOBE NEWSWIRE) -- MEDTOX Scientific, Inc. (Nasdaq:MTOX) today announced that the Federal Trade Commission has granted early termination of the waiting period...
ST. PAUL, Minn., July 12, 2012 (GLOBE NEWSWIRE) -- MEDTOX Scientific, Inc. (Nasdaq:MTOX) today announced results for the second quarter ended June 30, 2012. Highlights from the quarter compared...
ST. PAUL, Minn., June 28, 2012 (GLOBE NEWSWIRE) -- MEDTOX Scientific, Inc. (Nasdaq:MTOX), announced in its definitive proxy statement on Schedule 14A that it has established a record date and a...
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of MEDTOX Scientific, Inc. (“MEDTOX” or the “Company”...
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of MEDTOX Scientific, Inc. (“MEDTOX” or the “Company”...
Harwood Feffer LLP Announces Investigation of MEDTOX Scientific Inc. PR Newswire NEW YORK, June 6, 2012 NEW YORK, June 6, 2012 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating...
Law Office of Brodsky & Smith, LLC Announces Investigation of MEDTOX Scientific, Inc. PR Newswire BALA CYNWYD, Pa., June 5, 2012 BALA CYNWYD, Pa., June 5, 2012 /PRNewswire/ -- Law office of...
Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of MEDTOX Scientific, Inc. PR Newswire DALLAS, June 5, 2012 DALLAS, June 5, 2012 /PRNewswire/ -- Securities...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
